Obesity, which has increased in most developed countries in the past few decades, is the result of genetics, environment, and individual choices. Economics is useful for studying the individual choices that lead to obesity, explanations for the recent rise in obesity, the treatment options for obesity, and the costs and consequences of obesity for the individual and society. The papers in this volume, devoted to the economics of obesity, illustrate the wide usefulness of the economic approach. The papers in the first section propose and test economic explanations for food-consumption choices...

Part of a series which focuses on health economics and health services research, this volume discusses topics including cost-benefit evaluations in mental health and the demand for health care for the treatment of mental problems among the elderly.

Part of a series which focuses on health economics and health services research, this volume discusses a variety of topics in the field.

Much of the debate about health policy in the United States has focused on the availability of health insurance coverage and the relatively large number of individuals who are uninsured. While tackling the problem of the uninsured might improve access to and utilization of health care, it would likely have little effect on the health of the population, as there is only a weak connection between health insurance coverage and health. Expanding health insurance coverage alone is unlikely to significantly improve the health of the population or narrow health disparities within the population,...

The fields of pharmaceutical economics and health economics/policy are reaching a point of convergence. This is due to both the widespread availability of pharmaceutical treatments, accompanied by broader insurance coverage, and the regulation of prescription drugs in both private and government plans. This book will bridge the gap. We will explore developments in both U.S. and International setting. The system of the U.S. is characterized by a mix of private and government insurance for prescription drugs with the expansion of Medicare Part D. Most other developed countries are characterized...

Medical technology broadly defined to include all aspects of the process of treating disease (e.g., pharmaceuticals, medical devices, and surgical procedures) is profoundly important for individual health and, consequently, also for general welfare. Advances in medical technology convey the prospect of both improved population health and increased general welfare. However, because of the extensive regulation of the markets for healthcare goods and services, the development and application of medical technologies differs fundamentally from non-medical technological advances. In this volume of...

Considers the various topics in health economics including the production of and demand for health; the demand for medical care services; the financing of these services; the markets for physicians, nurses, dentists, hospitals, and drugs; the economics of substance use; health in developing countries; and, the economics of medical technology.

Low- and middle-income countries face major challenges to their health systems. These include a high burden of communicable disease and an emerging non-communicable disease burden. This work deals with the elements of health care financing, focusing on middle- and low-income settings.

This Volume focuses on human capital and health behavior. Content is based on an International symposium on Human Capital and Health Behavior, held by The Centre for Health Economics at the University of Gothenburg. Content will cover both theoretical and empirical aspects of the topic.